Moleculin Biotech
MBRX
MBRX
15 hedge funds and large institutions have $1.42M invested in Moleculin Biotech in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
CS
1
Credit Suisse
Zurich,
Switzerland
|
$0 |
2 |
2
Morgan Stanley
New York
|
$23K |
3 |
NFG
3
Next Financial Group
Houston,
Texas
|
$0 |